Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Alessandro M. Vannucchi, Jean Jacques Kiladjian, Martin Griesshammer, Tamas Masszi, Simon Durrant, Francesco Passamonti, Claire N. Harrison, Fabrizio Pane, Pierre Zachee, Ruben Mesa, Shui He, Mark M. Jones, William Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srdan Verstovsek

Research output: Contribution to journalArticlepeer-review

367 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib versus standard therapy for the treatment of polycythemia vera'. Together they form a unique fingerprint.

Medicine & Life Sciences